48,706
edits
Difference between revisions of "Esophageal adenocarcinoma"
Jump to navigation
Jump to search
Esophageal adenocarcinoma (view source)
Revision as of 16:09, 7 October 2015
, 16:09, 7 October 2015→IHC
(→IHC) |
(→IHC) |
||
| Line 103: | Line 103: | ||
*p53 +ve. | *p53 +ve. | ||
*COX-2 +ve. | *COX-2 +ve. | ||
*p16 +ve - but useless... as frequently positive in precursors. | *p16 +ve - but useless... as frequently positive in precursors.<ref name=pmid15617840>{{Cite journal | last1 = Hardie | first1 = LJ. | last2 = Darnton | first2 = SJ. | last3 = Wallis | first3 = YL. | last4 = Chauhan | first4 = A. | last5 = Hainaut | first5 = P. | last6 = Wild | first6 = CP. | last7 = Casson | first7 = AG. | title = p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations. | journal = Cancer Lett | volume = 217 | issue = 2 | pages = 221-30 | month = Jan | year = 2005 | doi = 10.1016/j.canlet.2004.06.025 | PMID = 15617840 }}</ref> | ||
==Sign out== | ==Sign out== | ||